Posts Tagged ‘biopharmaceutical production’

CHO cells have become the most important cell system for the biotechnological production of pharmaceuticals. Reasons for that are described in the article The increasing potential of chinese hamster ovary cells. A critical feature of a cell line used for production of therapeutics is to be clonal, which means origination from a single cell, to ensure a homogenous therapeutic product. The demonstration of clonal derivation can be a big effort for the pharmaceutical industry, but does it really ensure a homogenous product quality?